GSE159906
Targeting eIF4F Translation Initiation Complex with SBI-756 Sensitizes B Lymphoma Cells to Venetoclax
Through the study of translation regulation, we identify the disruption of eIF4F assembly as a promising approach to enhance venetoclax efficacy in non-Hodgkin's lymphoma. Overall design: Examination of the translation effects of SBI-756 on a non-Hodgkin's lymphoma cell line.